Arrowhead Research Corporation to Present at Upcoming Scientific Conferences

Published: Jun 14, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that the company will present data on the Dynamic PolyConjugateâ„¢ (DPC) siRNA delivery system and the ARC-520 hepatitis B drug candidate at three upcoming scientific conferences.

Help employers find you! Check out all the jobs and post your resume.

Back to news